PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
37.68
+1.85 (5.16%)
Last updated: Jul 14, 2025
SHE:301230 Revenue
PharmaResources (Shanghai) had revenue of 169.43M CNY in the quarter ending March 31, 2025, with 29.61% growth. This brings the company's revenue in the last twelve months to 583.17M, up 16.86% year-over-year. In the year 2024, PharmaResources (Shanghai) had annual revenue of 544.47M with 11.18% growth.
Revenue (ttm)
583.17M
Revenue Growth
+16.86%
P/S Ratio
8.84
Revenue / Employee
580.85K
Employees
1,004
Market Cap
5.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 544.47M | 54.75M | 11.18% |
Dec 31, 2023 | 489.72M | 10.83M | 2.26% |
Jan 1, 2023 | 478.88M | 30.67M | 6.84% |
Jan 1, 2022 | 448.21M | 165.22M | 58.39% |
Dec 31, 2020 | 282.99M | 37.79M | 15.41% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Jan 1, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |